ChemicalBook
English   Japanese   Germany   Korea

CP 532623

CP 532623, 261947-38-0, 结构式
CP 532623
CAS号:
261947-38-0
英文名:
(2R,4S)-4-[Acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylic acid 1-methylethyl ester
英文别名:
CP 532623;CP532623,CP 532623;CP 532623 >=98% (HPLC);(2R,4S)-4-[Acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylic acid 1-methylethyl ester;1(2H)-Quinolinecarboxylic acid, 4-[acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-methylethyl ester, (2R,4S)-
中文名:
CP 532623
中文别名:
化合物 T15004
CBNumber:
CB62750378
分子式:
C27H27F9N2O3
分子量:
598.5
MOL File:
261947-38-0.mol

CP 532623化学性质

熔点:
101.8 °C
沸点:
523.8±50.0 °C(Predicted)
密度:
1.38±0.1 g/cm3(Predicted)
储存条件:
2-8°C
溶解度:
DMSO: soluble20mg/mL, clear
形态:
powder
酸度系数(pKa):
-0.93±0.40(Predicted)
颜色:
white to beige
安全信息
WGK Germany: 3

CP 532623性质、用途与生产工艺

生物活性

CP-532623 是 CETP 抑制剂,可提高高密度脂蛋白胆固醇水平。CP-532623 与 Torcetrapib 的结构相似,并具有高度亲脂性。

靶点

CETP

体外研究

CP-532623 is highly lymphatically transported (28% of dose), and lymphatic transport is closely correlated with drug affinity for ex-vivo lymph lipoproteins or triglyceride emulsions and poorly relates to solubility in mixtures of lipoprotein core and/or surface lipids. CP-532623 alters the kinetics of lymph lipid transport and decreases lymph lipid transport in chylomicrons.

体内研究

CP-532623 (50 mg; oral administration; adult male greyhound dogs) treatment substantially transports into the lymphatic system (>25% dose) in fed and fasted dogs. Food enhances oral bioavailability (from 44 to 58%, respectively) and the proportion of the absorbed dose transports via the lymph (from 61 to 86% and from 68 to 83%, respectively). Lymphatic triglyceride transport is significantly lower in fed dogs administered CP-532623.

Animal Model: Adult male greyhound dogs (27-39 kg)
Dosage: 50 mg
Administration: Oral administration with a long-chain lipid formulation to fed lymphcannulated
Result: Substantially transported into the lymphatic system (>25% dose) in fed and fasted dogs. Food enhanced oral bioavailability and the proportion of the absorbed dose transported via the lymph.

CP 532623 上下游产品信息

上游原料

下游产品

CP 532623 试剂级价格

更新日期产品编号产品名称CAS编号包装价格
2024/04/30HY-123039CP 532623
CP-532623
261947-38-05mg2160元
2024/01/25HY-123039CP-5326231 mg2090元

CP 532623 生产厂家

全球有 11家供应商   CP 532623国内生产厂家
供应商联系电话电子邮件国家产品数优势度
广州爱纯医药科技有限公司 020-39119399 18927568969 isunpharm@qq.com 中国 4428 55
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司 021-61415566 800-8193336 orderCN@merckgroup.com 中国 51471 80
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 marketing@targetmol.com 美国 19892 58
上海源溪生物科技有限公司 021-58447131 13564518121 sales@dcchemicals.com 中国 9412 58
安耐吉化学&3A(安徽泽升科技有限公司) 021-58432009 400-005-6266 marketing1@energy-chemical.com 中国 44843 58
天津普西唐生物医药科技有限公司 010-60605840 15801484223 psaitong@jm-bio.com 中国 29778 58
TargetMol中国(陶术生物) 4008200310 marketing@tsbiochem.com 中国 24017 58
銳迪國際科技有限公司 18024082417 market@ubiochem.com 中国 9282 58
 

261947-38-0, CP 532623 相关搜索:

  • C27H27F9N2O3
  • 化合物 T15004
  • 261947-38-0
  • CP532623,CP 532623
  • CP 532623 >=98% (HPLC)
  • 1(2H)-Quinolinecarboxylic acid, 4-[acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-methylethyl ester, (2R,4S)-
  • CP 532623
  • (2R,4S)-4-[Acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylic acid 1-methylethyl ester
Copyright 2016 © ChemicalBook. All rights reserved